MOTUS GI HOLDINGS INC (MOTS) Stock Fundamental Analysis

NASDAQ:MOTS • US62014P5044

0.1735 USD
-0.09 (-34.06%)
At close: Apr 15, 2024
0.1512 USD
-0.02 (-12.85%)
After Hours: 4/15/2024, 8:19:47 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall MOTS gets a fundamental rating of 2 out of 10. We evaluated MOTS against 185 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of MOTS have multiple concerns. MOTS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year MOTS has reported negative net income.
  • MOTS had a negative operating cash flow in the past year.
  • In the past 5 years MOTS always reported negative net income.
  • MOTS had a negative operating cash flow in each of the past 5 years.
MOTS Yearly Net Income VS EBIT VS OCF VS FCFMOTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M -20M -25M

1.2 Ratios

  • The Return On Assets of MOTS (-178.25%) is worse than 92.31% of its industry peers.
  • With a Return On Equity value of -479.16%, MOTS is not doing good in the industry: 88.21% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -178.25%
ROE -479.16%
ROIC N/A
ROA(3y)-126.68%
ROA(5y)-106.33%
ROE(3y)-454.56%
ROE(5y)-332.05%
ROIC(3y)N/A
ROIC(5y)N/A
MOTS Yearly ROA, ROE, ROICMOTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -200 -400 -600

1.3 Margins

  • MOTS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MOTS Yearly Profit, Operating, Gross MarginsMOTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -10K -20K -30K -40K -50K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • MOTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MOTS has been increased compared to 1 year ago.
  • Compared to 1 year ago, MOTS has an improved debt to assets ratio.
MOTS Yearly Shares OutstandingMOTS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M
MOTS Yearly Total Debt VS Total AssetsMOTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of -34.76, we must say that MOTS is in the distress zone and has some risk of bankruptcy.
  • MOTS's Altman-Z score of -34.76 is on the low side compared to the rest of the industry. MOTS is outperformed by 91.79% of its industry peers.
  • MOTS has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.46, MOTS is doing worse than 62.05% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z -34.76
ROIC/WACCN/A
WACC10.68%
MOTS Yearly LT Debt VS Equity VS FCFMOTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M -20M

2.3 Liquidity

  • MOTS has a Current Ratio of 1.76. This is a normal value and indicates that MOTS is financially healthy and should not expect problems in meeting its short term obligations.
  • MOTS has a worse Current ratio (1.76) than 77.44% of its industry peers.
  • A Quick Ratio of 1.61 indicates that MOTS should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.61, MOTS is doing worse than 67.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.61
MOTS Yearly Current Assets VS Current LiabilitesMOTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • MOTS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 68.99%, which is quite impressive.
  • MOTS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -46.00%.
  • MOTS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.48% yearly.
EPS 1Y (TTM)68.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.19%
Revenue 1Y (TTM)-46%
Revenue growth 3Y47.21%
Revenue growth 5Y51.48%
Sales Q2Q%-41.82%

3.2 Future

  • MOTS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.56% yearly.
  • Based on estimates for the next years, MOTS will show a very strong growth in Revenue. The Revenue will grow by 206.79% on average per year.
EPS Next Y58.34%
EPS Next 2Y40.28%
EPS Next 3Y25.56%
EPS Next 5YN/A
Revenue Next Year337.5%
Revenue Next 2Y301.56%
Revenue Next 3Y206.79%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MOTS Yearly Revenue VS EstimatesMOTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
MOTS Yearly EPS VS EstimatesMOTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 -50 -100 -150 -200 -250

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • MOTS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year MOTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MOTS Price Earnings VS Forward Price EarningsMOTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MOTS Per share dataMOTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20 -25

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MOTS's earnings are expected to grow with 25.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.28%
EPS Next 3Y25.56%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • MOTS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

MOTUS GI HOLDINGS INC

NASDAQ:MOTS (4/15/2024, 8:19:47 PM)

After market: 0.1512 -0.02 (-12.85%)

0.1735

-0.09 (-34.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-18
Earnings (Next)05-08
Inst Owners0%
Inst Owner Change-99.17%
Ins Owners134.91%
Ins Owner Change0%
Market Cap872.70K
Revenue(TTM)324.00K
Net Income(TTM)-12.88M
Analysts82.86
Price Target8.47 (4781.84%)
Short Float %0.12%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)22.83%
Min EPS beat(2)-4.82%
Max EPS beat(2)50.49%
EPS beat(4)3
Avg EPS beat(4)21.64%
Min EPS beat(4)-4.82%
Max EPS beat(4)50.49%
EPS beat(8)7
Avg EPS beat(8)19.82%
EPS beat(12)10
Avg EPS beat(12)16.65%
EPS beat(16)12
Avg EPS beat(16)14.53%
Revenue beat(2)0
Avg Revenue beat(2)-45.1%
Min Revenue beat(2)-68.63%
Max Revenue beat(2)-21.57%
Revenue beat(4)0
Avg Revenue beat(4)-52.61%
Min Revenue beat(4)-90.59%
Max Revenue beat(4)-21.57%
Revenue beat(8)0
Avg Revenue beat(8)-47.11%
Revenue beat(12)3
Avg Revenue beat(12)-20.84%
Revenue beat(16)4
Avg Revenue beat(16)-26.2%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.61%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.69
P/FCF N/A
P/OCF N/A
P/B 0.32
P/tB 0.32
EV/EBITDA N/A
EPS(TTM)-28.56
EYN/A
EPS(NY)-11.9
Fwd EYN/A
FCF(TTM)-2.25
FCFYN/A
OCF(TTM)-2.23
OCFYN/A
SpS0.06
BVpS0.53
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -178.25%
ROE -479.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-126.68%
ROA(5y)-106.33%
ROE(3y)-454.56%
ROE(5y)-332.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 23.06%
Cap/Sales 32.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.76
Quick Ratio 1.61
Altman-Z -34.76
F-Score3
WACC10.68%
ROIC/WACCN/A
Cap/Depr(3y)57.67%
Cap/Depr(5y)82.07%
Cap/Sales(3y)63.47%
Cap/Sales(5y)141.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.19%
EPS Next Y58.34%
EPS Next 2Y40.28%
EPS Next 3Y25.56%
EPS Next 5YN/A
Revenue 1Y (TTM)-46%
Revenue growth 3Y47.21%
Revenue growth 5Y51.48%
Sales Q2Q%-41.82%
Revenue Next Year337.5%
Revenue Next 2Y301.56%
Revenue Next 3Y206.79%
Revenue Next 5YN/A
EBIT growth 1Y33.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y36.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.92%
OCF growth 3YN/A
OCF growth 5YN/A

MOTUS GI HOLDINGS INC / MOTS FAQ

What is the ChartMill fundamental rating of MOTUS GI HOLDINGS INC (MOTS) stock?

ChartMill assigns a fundamental rating of 2 / 10 to MOTS.


Can you provide the valuation status for MOTUS GI HOLDINGS INC?

ChartMill assigns a valuation rating of 1 / 10 to MOTUS GI HOLDINGS INC (MOTS). This can be considered as Overvalued.


Can you provide the profitability details for MOTUS GI HOLDINGS INC?

MOTUS GI HOLDINGS INC (MOTS) has a profitability rating of 0 / 10.


Can you provide the financial health for MOTS stock?

The financial health rating of MOTUS GI HOLDINGS INC (MOTS) is 2 / 10.